Physician profile
Susan E Almquist
NPI 1780885897
$4,368.14
in general payments reported to CMS, 2019-2025
39 companies · $399 in 2025
The $399 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $444 · 2021: $725 · 2022: $992 · 2023: $783 · 2024: $674 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,855.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $947.34 | 2019-2024 | Lo Loestrin Fe, Liletta |
| Mayne Pharma Commercial LLC | $374.85 | 2021-2025 | |
| Astellas Pharma US INC | $370.28 | 2022-2025 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $334.72 | 2019-2024 | Injectafer |
| Exeltis, USA INC. | $332.54 | 2019-2024 | Slynd |
| Organon LLC | $218.00 | 2021-2025 | Nexplanon |
| Evofem Biosciences, INC. | $207.82 | 2021-2025 | Phexxi, Solosec, Phexx |
| Myovant Sciences INC. | $189.48 | 2022 | |
| Novo Nordisk INC | $124.38 | 2019-2024 | Wegovy |
| Pfizer INC. | $98.97 | 2019-2024 | |
| Mission Pharmacal Company | $97.20 | 2019-2022 | |
| Therapeuticsmd, INC. | $97.07 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $76.98 | 2020 | |
| Exact Sciences Corporation | $66.07 | 2023-2024 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $60.05 | 2021-2022 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $53.40 | 2019-2020 | |
| Millicent US INC | $51.63 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Merck Sharp & Dohme LLC | $51.11 | 2019-2021 | |
| Agile Therapeutics, INC. | $50.82 | 2022-2023 | Twirla |
| Lilly USA, LLC | $48.60 | 2024-2025 | Zepbound |
| Biogen, INC. | $45.02 | 2024 | Zurzuvae |
| Vertical Pharmaceuticals, LLC | $37.67 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $36.23 | 2021 | |
| Heron Therapeutics, INC. | $35.16 | 2023 | Zynrelef |
| Becton, Dickinson and Company | $33.21 | 2019-2022 | |
| Renovia INC | $33.04 | 2021 | |
| Hologic Sales and Service, LLC | $32.34 | 2022-2023 | Aptima |
| Shield Therapeutics INC | $30.52 | 2024-2025 | |
| Currax Pharmaceuticals LLC | $29.26 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $29.19 | 2025 | Myfembree |
| Duchesnay USA Incorporated | $26.80 | 2019 | |
| Lupin INC. | $26.40 | 2020 | |
| Scynexis, INC. | $25.19 | 2022 | |
| Amag Pharmaceuticals, INC. | $23.81 | 2019 | |
| Urovant Sciences INC | $17.88 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $16.45 | 2023 | Exparel |
| Medicem INC. | $15.03 | 2021 | |
| Coopersurgical, INC. | $13.02 | 2021 | |
| Meditrina | $10.61 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Almquist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.